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Incorrect dosage of IQSEC2, a known intellectual disability
and epilepsy gene, disrupts dendritic spine morphogenesis
SJ Hinze1,2, MR Jackson1,2, S Lie1, L Jolly1,2, M Field3, SC Barry2, RJ Harvey4 and C Shoubridge1,2
There is considerable genetic and phenotypic heterogeneity associated with intellectual disability (ID), speciﬁc learning disabilities,
attention-deﬁcit hyperactivity disorder, autism and epilepsy. The intelligence quotient (IQ) motif and SEC7 domain containing
protein 2 gene (IQSEC2) is located on the X-chromosome and harbors mutations that contribute to non-syndromic ID with and
without early-onset seizure phenotypes in both sexes. Although IQ and Sec7 domain mutations lead to partial loss of IQSEC2
enzymatic activity, the in vivo pathogenesis resulting from these mutations is not known. Here we reveal that IQSEC2 has a key role
in dendritic spine morphology. Partial loss-of-function mutations were modeled using a lentiviral short hairpin RNA (shRNA)
approach, which achieved a 57% knockdown of Iqsec2 expression in primary hippocampal cell cultures from mice. Investigating
gross morphological parameters after 8 days of in vitro culture (8DIV) identiﬁed a 32% reduction in primary axon length, in contrast
to a 27% and 31% increase in the number and complexity of dendrites protruding from the cell body, respectively. This increase in
dendritic complexity and spread was carried through dendritic spine development, with a 34% increase in the number of
protrusions per dendritic segment compared with controls at 15DIV. Although the number of dendritic spines had normalized by
21DIV, a reduction was noted in the number of immature spines. In contrast, when modeling increased dosage, overexpression of
wild-type IQSEC2 led to neurons with shorter axons that were more compact and displayed simpler dendritic branching.
Disturbances to dendritic morphology due to knockdown of Iqsec2 were recapitulated in neurons from Iqsec2 knockout mice
generated in our laboratory using CRISPR/Cas9 technology. These observations provide evidence of dosage sensitivity for IQSEC2,
which normally escapes X-inactivation in females, and links these disturbances in expression to alterations in the morphology of
developing neurons.
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INTRODUCTION
Cognition requires the formation and continued reﬁnement of
synaptic networks of neurons in the brain. Neurons display
characteristic changes during development with outgrowth of
axons and dendrites, and the subsequent establishment of
synapses. Synapses are formed between axonal structures called
boutons (the presynaptic compartment) and small protrusions on
the dendrite called dendritic spines. These spines make up the
postsynaptic component of most excitatory synapses in the
mammalian brain. Dendrites of immature neurons have thin
headless protrusions, ﬁlopodia, that lack the necessary post-
synaptic components required for synapse function. With activity-
dependent maturation of neurons, the number of ﬁlopodia rapidly
decreases through pruning of these synaptic contacts with the
simultaneous increase in the number of mature or bulbous
spines.1–3 These spines can respond to extracellular signals and
show morphological plasticity. Remodeling of synapses continues
throughout life, with signiﬁcant structural and functional synaptic
plasticity during development in the late embryonic and early
postnatal periods when synapse density is highest.4 The
machinery driving the plasticity of dendritic spines involves
remodeling of the actin cytoskeleton.2,5 Actin dynamics and
membrane trafﬁcking is coordinated by the family of ADP
ribosylation factors (ARFs), members of the Ras superfamily of
small G proteins.6 Activation of ARFs is achieved by exchange of
GDP for GTP nucleotide by a family of guanine nucleotide
exchange factors (GEF) for the ARF family of GTP-binding proteins
(ARFGEF). Intelligence quotient (IQ) motif and SEC7 domain
containing Protein 2 (IQSEC2) is a GEF for ARF proteins7 and is
localized to excitatory synapses as part of the NMDA receptor
complex, via interactions with postsynaptic density proteins
including disks large MAGUK scaffold protein 4 (DLG4) also
known as PSD-95.8
Neurodevelopmental disorders are a large group of disorders
that display disease onset during periods of maturation and
development. Complex neuropsychiatric features of neurodeve-
lopmental disorders include intellectual disability (ID), speciﬁc
learning disabilities, attention-deﬁcit hyperactivity disorder, aut-
ism and epilepsy. These disorders are linked to changes in
development, involving alteration in neurogenesis, cell migration
and neuronal connectivity that are responsible for cognitive
deﬁcits in later life. There is considerable genetic and phenotypic
heterogeneity associated with these disorders. For example,
monogenic causes on the X-chromosome alone include oligo-
phrenin (OPHNI, a Rho GTPase activating protein; RhoGAP),9
Fragile X syndrome (FMR1),10,11 p21 protein (Cdc42/Rac)-activated
kinase 3 (PAK3),12 ARHGEF6 (a Rho guanine exchange factor;
RhoGEF)13 or FGD1 (a RhoGEF)14 recently reviewed.15 Patients and
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animal models of neurodevelopmental disorders with early
childhood onset show hallmarks of immature synaptic networks
in the form of an increased ﬁlopodia-to-spine ratio and abnormal
density of protrusions.16,17
We ﬁrst established the IQSEC2 gene [NM_001111125] (MIM
300522) as a genetic cause of ID due to missense variants in
X-linked familial cases.18 Since this report, high-throughput
sequencing in ID or epilepsy cohorts has identiﬁed de novo loss-
of-function IQSEC2 mutations in males and increasingly in
females.19–29 Abolition of enzymatic activity of IQSEC2 typically
leads to a more severe phenotype including epileptic encephalo-
pathy in both sexes. Recently, we have identiﬁed four male
patients with ID and early speech disturbances with submicro-
scopic duplications at Xp11.22 containing the known ID genes
IQSEC2 and KDM5C30 indicating that dosage of IQSEC2 and/or
KDM5C, or a combination thereof is important. In this study, we
model the human disease state using knockdown and over-
expression of IQSEC2 and generate the ﬁrst knockout mouse
model for Iqsec2 to investigate the impact and dosage of this gene
on neuronal morphology, and in particular dendritic spine
development.
MATERIALS AND METHODS
Animals
All animal procedures were approved by the Animal Ethics committee of
the University of Adelaide, the SA Pathology Animal Ethics committee and
the Animal Ethics committee of the Women’s and Children’s Hospital,
Adelaide, SA, Australia. The pregnant Swiss dams were killed by cervical
dislocation followed by decapitation of embryos.
Construction of IQSEC2-containing vectors
The full-length IQSEC2 in pCAGGS incorporating an N-terminal FLAG-tag
were a gift from Dr Randall Walikonis (University of Connecticut, Mansﬁeld,
CT, USA). The patient mutations and a previously reported dominant-
negative IQSEC2E849K mutation were generated by site-directed mutagen-
esis (Stratagene, San Diego, CA, USA) using pCAGGSFLAGIQSEC2: as a
template. All clone preparations were veriﬁed by sequencing the entire
IQSEC2 complementary DNA (cDNA).
Generation of shRNA triggers to knock down Iqsec2
Four shRNA sequences predicted to knock down mouse Iqsec2 expression
were designed using BLOCK-iT RNA designer (Invitrogen, Waltham, MA,
USA). The sequences were chosen on the basis of species speciﬁcity and
location within the messenger RNA (mRNA) transcript; shRA (5′-
GGAAGTTCAGTCACCACATCT-3′) matches 3′ to the IQ-like domain in exon
4; shRB (5′-GCGACCTTCTAGTAGGCATCT-3′) and shRC (5′-TCATCATCTTT
AATGCTCCTA-3′) are located in the Sec7 (exon 9) and the Pleckstrin
Homology (exon 12) domains, respectively; All three triggers have at least
2 bp mismatched to the human sequence and matched identically to both
NM_001114664 and NM_001005475 isoforms of mouse Iqsec2. Construc-
tion of shRNA clones was performed as outlined in Brown et al.,31 details
supplied in Supplementary Methods. Endo-free maxi DNA preparations
(Qiagen, Chadston, VIC, Australia) were used to generate large quantities of
high-quality DNA for transfection and lentiviral packaging.
Lentivirus was prepared by transfecting three packaging vectors (VSV-g
3.75 μg DNA, Rev 6.25 μg DNA and gag/pol 7.5 μg DNA) together with
12.5 μg DNA of transfer vector plv-C-shRNA into packaging HEK293T cells.
The media were changed after 18 h, and supernatant containing virus
particles collected after a further 48 h. The supernatant was ﬁltered
through 0.45 μm ﬁlter, then centrifuged at 20 000 r.p.m. at 4 °C for 90 min.
The pelleted lentiviral particles were resuspended in phosphate-buffered
saline (PBS) in an appropriate volume and frozen in aliquots at − 80 °C. The
titer of each viral preparation was assessed using transduction rates of
HEK293T cells (transduction efﬁciency determined using EGFP expression
assayed by ﬂow cytometry) with values ranging between 1.4 × 107 and
1.1 × 109 particles per milliliter.
Neuronal cultures
The pimary hippocampal cultures were generated from embryonic day 17.5
(E17.5) Swiss mice. Unless stated otherwise, all cell culture reagents and
supplements were sourced from Life Technologies (Waltham, MA, USA). The
dissociated neurons were plated onto Biocoat poly-L-lysine coverslips (BD
Biosciences, North Ryde, NSW, Australia) at 1.5 × 105 cells per well in 24-well
plates in Neurobasal-A medium supplemented with 10% fetal bovine serum
(GIBCO, Waltham, MA, USA), 2% B27 and 2 mM glutamine. All the media
were removed after 18 h and replaced with media excluding fetal bovine
serum. The media were supplemented with 25 μM glutamate (Sigma,
Sydney, NSW, Australia) for the ﬁrst 6 days in culture. Routinely, half the
volume of the media was refreshed every 2–3 days.
Before plating, primary hippocampal neurons were nucleofected with
the Amaxa Mouse Neuron Nucleofector Kit (Lonza, Basel, Switzerland)
using the protocol for mouse hippocampal neurons (program O-005). For
transfection of shRNA constructs, a ratio of 1 μg DNA to 1 × 106 cells was
routinely used. For overexpression studies, a ratio of 12 μg DNA to 1 × 106
cells was used, with a further 1–2 μg of pmaxGFP DNA (Lonza) in GFP-
spiked groups. The individual cells were selected on the basis of GFP and
FLAG (IQSEC2) expression. The cells were collected at days in vitro (DIV) 8,
15 and 21. The cells were ﬁxed with 4% formaldehyde in PBS at room
temperature for 1 h and stored at 4 °C until time of assay.
To generate larger cell numbers for RNA and protein analysis, cortical
cultures (entire cortex including the hippocampus) were generated as
stated for hippocampal cultures. The neurons were plated at 1.24 × 106
cells per 60 mm2 dishes (BD Biosciences) coated with poly-L-lysine (Sigma),
and 7× 104 cells per well in 24-well plates on a coverslip. Lentiviral
transduction were performed 1 day post plating by the addition of
4.7 × 105 particles of virus per 60 mm2 dish (multiplicity of infection at 0.4)
at the ﬁrst full media change (switching to fetal bovine serum-depleted
media) on DIV1. The virus was subsequently removed 24 h later via
complete media change. The neurons were harvested for RNA or protein at
DIV8. The knockdown of Iqsec2 was conﬁrmed by immunoblot analysis and
quantitative real-time reverse transcriptase PCR.
Quantitative real-time reverse transcriptase PCR
Total RNA was extracted using Trizol (Life Technologies) and RNeasy Mini
Kit (Qiagen) and treated with DNase I (Qiagen). We primed 2 μg of RNA
with 1 μg of random hexamers and then subjected it to reverse
transcription using the SuperScript III Reverse Transcriptase Kit (Invitrogen).
The efﬁciency of transcription was tested by PCR using primers speciﬁc to
the ubiquitously expressed Actb gene. Quantitative PCR was performed in
triplicate using StepOnePlus Realtime PCR system (Applied Biosystems,
Waltham, MA, USA) with products quantiﬁed by a relative standard curve
prepared using adult mouse brain cDNA at neat, 10, 102, 103, 104 dilution
factors for each primer pair. The primer sequences are provided in
Supplementary Methods.
Protein analysis
For protein analysis, the cell lysates were prepared as previously
described.32 The proteins were separated using 4–12% Tris-acetate SDS
polyacrylamide gel electrophoresis in Tris-acetate running buffer, trans-
ferred to nitrocellulose membrane (PALL, Port Washington, NY, USA) for
immunoblotting. The membranes were blocked 5% bovine serum
albumin in Tris-buffered saline with 0.1% Tween-20 and incubated with
appropriate primary and secondary antibodies (listed below) and
developed with enhanced chemiluminesence method (GE Healthcare,
Little Chalfont, UK).
Immunoﬂuorescence and microscopy
The cells were ﬁxed using formaldehyde and permeabilized in 0.2% Triton
in PBS for 5 min and blocked in 5% skim milk in Tris-buffered saline with
0.1% Tween-20. The primary and secondary antibodies were incubated in
1% skim milk in Tris-buffered saline with 0.1% Tween-20, with appropriate
washing in Tris-buffered saline with 0.1% Tween-20 in between incuba-
tions. The cells were mounted using ProLong Gold Antifade with DAPI (Life
Technologies). The neurons were washed twice with PBS after the
secondary antibody and then counterstained with phalloidin (AlexaFluor
Phalloidin-647; 1:1000, A22287, Life Technologies incubated in 1% bovine
serum albumin in PBS) or CellTracker CM-DiI (C-7000, Molecular Probes,
Waltham, MA, USA; at 1 μM CM-DiI in PBS for 20 min at 4 °C) before
washing and mounting as above.
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Fluorescence was viewed using the Axioplan2 microscope (Carl Zeiss,
Jena, Germany) ﬁtted with an HBO 100 lamp (Carl Zeiss). The images were
captured using an Axiocam Mrm camera and Axio Vs40 v4.5.0.0 software
(Axiovision, Carl Zeiss). The analysis of images was conducted using ImageJ
software. For gross morphology, a straight line of deﬁned length was
drawn across the image with the center of the line aligned to the center of
the cell soma. Using the Concentric Circle plugin on ImageJ software, the
inner circle was set at 10 (and wholly contained within the cell soma) and
the concentric circles arrayed at intervals of 24 μm. The number of times
the neuron intercepted each odd concentric circle (excluding the circle
within the soma) was counted manually. The numbers of biological
replicates and individual neuron numbers counted for each measure are
provided in the sample size and statistics.
To examine changes to dendritic spines, phalloidin-stained neurons
expressing EGFP (that is, transduced or transfected) were selected and
Z-stack images of neurons were acquired using a × 63 objective. The
images were analyzed using Zeiss LSM 510 software. The segments of
dendrite were manually traced and all protrusions stemming from the
segment were added as regions of interest. The length of protrusions were
measured by manually drawing a line from the base of the spine neck to
the furthest point at the end of the spine. The protrusions were classiﬁed
as ﬁlopodia if the length exceeded 3 μm, with shorter structures classed as
spines. The spines were further subcategorized on the basis of length
using the criteria from Vanderklish and Edelman,33 where stubby were
o0.5 μm in length, mushroom were 0.5–1.25 μm in length and thin were
1.25–3.0 μm in length. For each neuron, a primary or secondary dendritic
segment of 35 μm in length or greater was examined.
Antibodies
For immunoﬂuorescence studies, the primary antibodies used were mouse
anti-FLAG (M2; 1:1000; Sigma F1804); chicken anti-MAP2 (1:1000; Millipore
AB15452); mouse anti-tau (1:1000; Millipore MAB3420) and rabbit anti-β-
tubulin-III (1:400; Sigma T2200). The secondary antibodies used for
immunoﬂuorescence were all sourced from Thermo Fisher (Waltham,
MA, USA) and include; donkey anti-mouse IgG Alexa555 (1:2000 A31570);
donkey anti-mouse IgG Alexa647 (1:1000 A31571) and donkey anti-rabbit
IgG Alexa555 (1:2000 A31572). For immunoblotting, the primary antibodies
were rabbit anti-hIQSEC2 (1:2000; details in Supplementary Methods),
mouse β-actin (AC-74; 1:20 000; Sigma A2228) and rabbit anti-IQSEC3
(1:500; Abcam AB107853). Secondary antibodies from DAKO (Santa Clara,
CA, USA) were goat anti-mouse HRP (1:2000 P0447) and goat anti-rabbit
HRP (1:2000 P0448).
Sample size and statistics
In neuronal cultures with shRNA knockdown, a minimum sample size of 22
was required to achieve a power of 80% with P=0.05 to detect a minimum
difference in means of 0.5. A minimum number of three biological
replicates were performed to ensure reproducible and robust changes. The
images were captured and analysis undertaken with the investigator
blinded to treatment or genotype. For the shRNA knockdown studies, each
treatment group was tested at the three different time points in culture
with the following sample numbers; morphological measures on neurons
at 8DIV from shRL (n= 47), shRA (n=39), shRB (n=34) and shRC (n= 42)
treatments. At 15DIV, the number of neurons/segments/protrusions
(ﬁlopodia and spines) measured from shRL (n= 18/62/528), shRA (n= 15-
/53/813), shRB (n=12/35/244) and shRC (n=18/55/555). At 21DIV, the
number of neurons/segments/protrusions (ﬁlopodia and spines) measured
from shRL (n=4/14/222), shRA (n=7/15/241), shRB (n=5/12/155) and shRC
(n=7/16/212). Overexpression studies were also tested at the two different
time points in culture with the following sample numbers at 8DIV neurons
from GFP (n= 22), WT-IQSEC2 (n=36) and IQSEC2E849K (n=22). At 21DIV,
the number of neurons/segments/protrusions (ﬁlopodia and spines)
measured from GFP (n=8/16/209), WT-IQSEC2 (n= 6/10/91) and
IQSEC2E849K (n= 5/13/111).
Statistical analysis on these measures was performed using SAS
software, version 9.4 for Windows (SAS Institute, Cary, NC, USA). In cases
of three groups, when normal distribution of data were assumed, a one-
way analysis of variance was run to test whether there was an overall
difference among the groups, and then planned comparisons were
conducted to test difference between speciﬁc groups. Alternatively, when
data were not distributed normally, a Kruskal–Wallis Test was run to test
whether there was an overall difference among the groups, and then
speciﬁc pairwise tests using the Wilcoxon rank-sum/Mann–Whitney U-test
were conducted to test differences between speciﬁc groups. For
comparisons of two treatments, independent t-tests and Wilcoxon rank-
sum tests were used.
Cultures from the KO mice were performed across two biological
replicates, each consisting of two pooled litters, generating 13 and 17
embryos, respectively. In total, 32 wild-type and 39 Iqsec2 KO neurons were
analyzed, respectively. Statistical analysis was performed using a Chi-
squared test and complimentary Fisher's exact test of independence.
RESULTS
Speciﬁc knockdown of Iqsec2
Nomenclature; Human: IQSEC2 (gene or RNA)/IQSEC2 (protein) vs
Mouse: Iqsec2 / Iqsec2. To investigate the impact of Iqsec2
knockdown on the gross morphology of neurons and the
development of dendritic spines, we designed shRNA triggers
interspersed across the full-length mRNA. The triggers shRA, shRB
and shRC were to the open reading frame (Figure 1a), and
speciﬁcally targeted mouse Iqsec2 and not other family members
Iqsec1 and Iqsec3 (Figure 1b). As a control, we used shRNA
targeted to the luciferase gene, shRL. The shRNA triggers were
cloned into a lentiviral transfer vector that permits expression of
the shRNA together with EGFP. Lentiviral particles were generated
and used to transduce cultured primary hippocampal and cortical
neurons, resulting in 83–98% transduction rates (based on EGFP
expression, data not shown).
Knockdown of Iqsec2 expression in these cultures was achieved
with shRA and shRB, which reduced Iqsec2 mRNA expression by
52% and 48%, respectively (Figure 1c) and both lead to a marked
decrease in the abundance of Iqsec2 protein (Figure 1d). By
contrast, the shRC trigger resulted in a more modest knockdown
of Iqsec2 at both the mRNA and protein levels when compared
with the luciferase control (Figures 1c and d). These data were
consistent across three separate neuronal harvest, culture and
infection rounds (data not shown). At the mRNA level, Iqsec1 is
69% homologous with Iqsec2, while Iqsec3 is even lower at 58%.
The shRNA triggers targeted regions of low homology (Figure 1b),
therefore diminishing the likelihood of direct interference. As
expected, the expression of Iqsec1 in these cells was not markedly
impacted by any of the triggers (Figure 1e). Interestingly, although
the expression of Iqsec3 was reduced at the mRNA level with the
three speciﬁc Iqsec2 triggers (Figure 1f), we did not see a reduction
to the level of Iqsec3 protein in any case (Figure 1d). Taken
together, these data indicated that the three triggers shRA, shRB
and shRC were targeting Iqsec2.
Knockdown of Iqsec2 expression leads to altered morphology of
developing hippocampal neurons
To assess the effect of Iqsec2 knockdown, dissociated neurons
were isolated from E17.5 wild-type mice and nucleofected
with shRNA constructs which co-express EGFP, and analyzed after
8 days of in vitro culture (8DIV). Knockdown of Iqsec2 resulted
in neurons with greater neurite complexity compared with the
control shRL (Figures 2a–d). To quantify these differences,
we performed a modiﬁed Sholl analysis: concentric circles
were overlaid on imaged neurons, centered over the cell soma
and the average number of neuron interceptions at increasing
radii scored. Neurons nucleofected with shRA and shRB have
extensions further from cell soma than either control shRL or shRC
(Figure 2e).
We assessed the complexity of the neurons using multiple
metrics. The number of times the neuron intercepted a concentric
circle was signiﬁcantly increased in the knockdown of Iqsec2 with
shRA and shRB when compared with shRL control or the more
modest reduction in Iqsec2 expression of the shRC treatment
(Figure 2f). The number of projections from the cell body
(Figure 2g), and the branching of the neurites measured by the
number of termini (Figure 2h) was both signiﬁcantly increased in
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shRB compared with the shRL control. Interestingly, both these
measures were also higher in the other two knockdown triggers of
shRA or shRC, but the changes were not signiﬁcant compared with
shRL. The spread of the neurite processes captured by measuring
the furthest concentric circle reached by the primary axon was
signiﬁcantly increased for the knockdown of Iqsec2 with shRA
compared with all other treatments (Figure 2i). This may be in part
due to the signiﬁcantly shorter length of the primary axon
Figure 1. shRNA knockdown of Iqsec2. (a) Schematic of the IQSEC2 protein with domains highlighted; coiled coil (horizontal stripes), IQ-like
(white), Sec7 (dark gray), Pleckstrin Homology (PH; diagonal stripes), PDZ binding motif (black). The locations of shRNA triggers are shown
below relative to the domains. (b) Clustal W analysis of Iqsec family mRNA at shRNA target regions. Iqsec1 shares 69% and Iqsec3 shares 58%
identity to Iqsec2 at the mRNA level. The nucleotide bases that differ from Iqsec2 are shaded black and the sequences targeted by the shRNA
are boxed. (c) Expression of Iqsec2 is reduced in primary neurons infected for 8 days with shRNA lentiviral vectors shRA and shRB compared
with the shRL control. (d) Iqsec2 protein levels detected via western blot analysis of 20 μg protein from transduced primary neurons. Neurons
infected with shRA and shRB vectors show reduced protein levels of Iqsec2 but no change in Iqsec3 protein levels. ActB was used as a loading
control for each gel and a representative image is shown. (e) Expression of Iqsec1 was not markedly reduced with either of these triggers
against Iqsec2, however, we noted a decreased expression of Iqsec3 (f). Relative expression of genes was normalized to the expression of the
reference gene ActB. Relative gene expression for shRA- and shRB (light gray)-treated neurons is presented in comparison with shRL (white),
which is deﬁned as 1. IQSEC2, intelligence quotient motif and SEC7 domain containing protein 2 gene; mRNA, messenger RNA; shRNA, short
hairpin RNA.
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measured for both shRB and shRC compared with shRL (Figure 2j).
Interestingly, when considering the impact of dosage of Iqsec2 on
these measures, the shRC trigger with only a very modest
reduction to Iqsec2 expression (Figure 1) provides a good control
to the more robust knockdown achieved with shRA or shRB.
Except for primary axon length (Figure 2j), the measures for
neurons with shRC treatment were not signiﬁcantly different to
neurons treated with shRLuc control. This was in comparison with
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the signiﬁcantly increased values across the various morphological
measures for neurons treated with shRA or shRB (or both;
Figures 2f–i).
Knockdown of Iqsec2 expression increases the density of dendritic
spines
When dissociated hippocampal neurons are cultured, the number
and maturity of dendritic spines increases steadily, peaking at
3 weeks in culture. Across this time, the proportion of ﬁlopodia
declines concordant with a rise in the number of smaller
mature spines. By 3 weeks in culture, dendritic spines have the
characteristics of synaptic terminals and are similar to those seen
in vivo.34 To investigate the impact of knockdown of Iqsec2 on
spine morphology, we analyzed the density and type of dendritic
protrusions of hippocampal neurons. After 15 days in culture
(15DIV), Iqsec2 knockdown using the shRA and shRB triggers
resulted in signiﬁcant increases of 35% and 44%, respectively in
the density of protrusions compared with controls (Figure 3a).
However, when the dosage of Iqsec2 expression was not markedly
altered in the short hairpin trigger that resulted in less effective
knockdown of Iqsec2, there was only a very modest and not
signiﬁcant increase of 13% in protrusion density compared with
the controls. The increase in protrusion density compared with
Figure 2. Knockdown of Iqsec2 expression leads to altered morphology of developing hippocampal neurons. Hippocampal neurons were
examined after 8 days in culture (8DIV) for gross morphological measures following knockdown of endogenous Iqsec2. In the top panel,
pictomicrographs of hippocampal neurons transfected with (a–d) control shRL, shRA, shRB and shRC, respectively. (e) Scholl analysis of
neuron interceptions on concentric circles at distance from the cell soma show broader spread for neurons with knockdown of Iqsec2;
(control shRL pale gray dotted line; shRA solid dark gray line, shRB dark gray dashed line; shRC in pale gray solid line). Morphological measures
include the number of times the neuron intercepted the concentric circles (f), the number of projections from the cell body (g), number of
dendrite termini (h), the furthest concentric circle reached by the primary axon (i) and the length of the primary axon (j) for neurons
transfected with shRNA vectors to reduce Iqsec2 expression (control shRL in white bars; shRA and shRB analysis in dark gray bars; shRC in pale
gray bars). Data represent mean+s.e.m., from shRL (n= 47), shRA (n= 39), shRB (n= 34) and shRC (n= 42) treated neurons from three biological
replicates. Scale bar, 100 μM. Signiﬁcance *Po0.05 vs shRL and ^Po0.05 vs shRC. DIV, days in vitro; IQSEC2, intelligence quotient motif and
SEC7 domain containing protein 2 gene; shRNA, short hairpin RNA.
Figure 3. Knockdown of Iqsec2 expression increases the density of protrusions in hippocampal neurons. The density of protrusions on
dendrites in hippocampal neurons transfected with shRNA vectors to reduce Iqsec2 expression were measured after 15 (15DIV; a) and 21 days
in culture (21DIV; b); control shRL (white bars), shRA and shRB (dark gray bars), shRC (pale gray bars). At 15DIV (c) and 21DIV (d), the
percentage of the total protrusions were divided into categories of diminishing size, as indicated on the right hand side of the ﬁgure, with
stubby spines (dark gray), mushroom spines (medium gray), thin spines (pale gray) and ﬁlopodia in hatched bars. Data represent mean+s.e.m.
At 15DIV, the number of neurons/segments/protrusions (ﬁlopodia and spines) measured from shRL (n= 18/62/528), shRA (n= 15/53/813),
shRB (n= 12/35/244) and shRC (n= 18/55/555). At 21DIV, the number of neurons/segments/protrusions (ﬁlopodia and spines) measured from
shRL (n= 4/14/222), shRA (n= 7/15/241), shRB (n= 5/12/155) and shRC (n= 7/16/212). Measures for each group from three biological
replicates. Signiﬁcance *Po0.05 or #Po0.001 compared with shRL control. DIV, days in vitro; IQSEC2, intelligence quotient motif and SEC7
domain containing protein 2 gene; shRNA, short hairpin RNA.
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controls was diminished at 21 days in culture (21DIV; Figure 3b).
To examine changes to the maturity of the spines on neurons with
altered Iqsec2 expression, each of the protrusions were classiﬁed
as ﬁlopodia (if the length exceeded 3 μm) or spines (if length less
than 3 μm). The spines were further subclassiﬁed on the basis of
length using the criteria from Vanderklish and Edelman33 as
stubby (o 0.5 μm in length), mushroom (0.5–1.25 μm in length)
and thin (1.25–3.0 μm in length). At 15DIV, we did not observe a
consistent change to the proportion of spines to ﬁlopodia
between the shRL controls and Iqsec2 knockdown triggers
(Figure 3c). In neurons allowed to continue development in
culture until 21DIV, we identiﬁed a modest reduction in the
proportion of longer immature ﬁlopodia in neurons nucleofected
with Iqsec2 knockdown triggers compared with shRL controls,
particularly shRA (Figure 3d). The concomitant increase in
dendritic spines was observed across all subclassiﬁcations of
spine types.
Dosage of IQSEC2 alters the morphology of developing neurons
and increases the maturity of dendritic spines
To investigate further the impact of dosage of Iqsec2 expression
on the development of neurons, overexpression of wild-type
IQSEC2 was compared with GFP transfected controls. The IQSEC2
Figure 4. Dosage of IQSEC2 alters the morphology of developing neurons and increases the maturity of dendritic spines. Morphological
measures examined after 8 days in culture (8DIV) include the number of projections from the cell body (a), number of dendrite termini (b), the
number of times the neuron intercepted the concentric circles (c), the furthest concentric circle reached by the primary axon (d) and the
length of the primary axon (e) for hippocampal neurons transfected with overexpression of IQSEC2 wild-type. At 21 days in culture (21DIV), the
density of protrusions on dendrites in hippocampal neurons with overexpression of IQSEC2 (f) was measured. Control GFP alone (white bars),
wild-type IQSEC2 (WT; black bars), IQSEC2E849K dominant-negative mutation (E849K; light gray bars). The percentage of the total protrusions at
21DIV were divided into categories of diminishing size, as indicated on the right hand side of the ﬁgure, with stubby spines (dark gray),
mushroom spines (medium gray), thin spines (pale gray) and ﬁlopodia in hatched bars (g). Data represents mean+s.e.m. 8DIV neurons from
GFP (n= 22), WT-IQSEC2 (n= 36) and IQSEC2E849K (n= 22) for each group from three biological replicates. At 21DIV, the number of neurons/
segments/protrusions (ﬁlopodia and spines) measured were from GFP (n= 8/16/209), WT-IQSEC2 (n= 6/10/91) and IQSEC2E849K (n= 5/13/111).
Signiﬁcance *Po0.05 or #Po0.001 compared with GFP alone control. DIV, days in vitro; GFP, green ﬂuorescent protein; IQSEC2, intelligence
quotient motif and SEC7 domain containing protein 2 gene.
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cDNA is considerable in size (IQSEC2: NM_0011111125 is 4464 bp
in the pCAGGS vector backbone of over 4790 bp) and as such the
impact of the introduction of such a large construct to neurons in
culture on the morphology independent to the speciﬁc impact of
the overexpressed protein was unclear. To attempt to control for
this, we used a dominant-negative mutation E849K that changes
the invariant E residue of the Sec7 domain and lacks Arf-GEF
enzymatic activity.35 Our previous use of this variant indicates a
signiﬁcant reduction (4 sixfold) to the Arf-GEF enzymatic activity
in vitro.18 Hence, when analyzing the data, we were principally
looking for changes in morphology observed with wild-type
IQSEC2 in comparison with both the IQSEC2E849K mutant and GFP
controls.
At the early time points in culture, overexpression of wild-type
IQSEC2 signiﬁcantly reduced the number of projections from the
cell body (Figure 4a) and resulted in a subtle reduction in the
number of neurite termini (Figure 4b) compared with both GFP
alone and the IQSEC2E849K mutant neurons. This was in contrast to
Figure 5. Cortical neurons from Iqsec2 knockout (KO) mice demonstrate early gross morphological changes when compared with their wild-
type (WT) counterparts. (a) The exon–intron structure of the longest isoform of IQSEC2 gene [NM_0011111125] has 15 exons, with the ATG,
open reading frame and stop codon positions in black and 5′ and 3′ untranslated regions in light gray. The sequence of exon 3 to exon 13 are
identical (boxed with solid gray line). The region targeted by CRISPR/Cas9 is highlighted below with knockout of exon 3 shown at the gDNA
level (below dotted box) and the PCR amplicons in the panel on the left depicts the absent Iqsec2 mRNA expression across the exon 2–3
junction and absent Iqsec2 protein abundance in hemizygous males (KO/Y) compared with wild-type (+/Y, WT) controls. Heterozygous
females (KO/+) and their wild-type controls (+/+) are shown for reference, as heterozygous females were used to generate subsequent
experimental embryos. (b) The absence of PCR amplicons and Iqsec2 protein abundance was conﬁrmed in cortical neurons extracted from
hemizygous (KO) males compared with wild-type (WT) controls. Representative pictomicrographs of cortical neurons spiked with 0.5 μg
pmaxGFP from WT and KO males. Scale bar, 100 μM. (c–e) Neurons were examined after 8 days in culture (8DIV) with measures for WT (white
bars) or KO neurons (dark gray bars) including the proportion of primary axons which change quadrant (1 quadrant= 45 degrees; c), number
of quadrants changed (d) and proportion of neurons where dendrites project further than concentric circle 5 (CC5; e). Data represent mean+s.
e.m., from neurons from Wt (n= 32) and Iqsec2 KO (n= 39), from cultures of two biological replicates consisting of two pooled litters,
generating 13 and 17 embryos, respectively. *Po0.05 indicates signiﬁcant difference between WT and KO neurons. DIV, days in vitro; gDNA,
genomic DNA; IQSEC2, intelligence quotient motif and SEC7 domain containing protein 2 gene; mRNA, messenger RNA.
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the increases in both these measures when the activity of Iqsec2
was knocked down. However, in agreement with the data from
the knockdown of Iqsec2, overexpression of wild-type IQSEC2
resulted in a reduced number of times the neuron intercepted a
concentric circle (Figure 4c) and a signiﬁcant reduction in both the
furthest concentric circle reached by the primary axon and the
length of the primary axon (Figures 4d and e) when compared
with GFP alone. However, each of these measures was also
reduced in the IQSEC2E849K mutant treated neurons when
compared with GFP alone. We cannot rule out that the delivery
and expression from the plasmid itself is contributing to a
reduction in these morphological measures. As we were delivering
full-length IQSEC2, this outcome raises the possibility that another
aspect of IQSEC2 function that does not relate to the Sec7 enzyme
activity (for example, IQ domain or PDZ domain interactions) may
be impacting these morphological measures. When considered
together with the data from the knockdown of Iqsec2, we
demonstrate that the number of projections from the cell body
and neurite termini are both impacted in a dosage-dependent
manner with discordant outcomes depending on knocking down
Iqsec2 or overexpressing IQSEC2. However, the measures high-
lighting development and growth of the axon were reduced with
any alteration to Iqsec2/IQSEC2 expression.
At longer time points in culture, neurons overexpressing wild-
type IQSEC2 displayed a slight decrease in the density of
projections on dendrites (12% at 15DIV and 8% at 21DIV), with a
signiﬁcant reduction (22% at 21DIV) for the IQSEC2E849K mutant
compared with GFP alone (Figure 4f). When we examined the
maturity of the spines on neurons with wild-type IQSEC2
overexpression, there was an increase in the proportion of stubby
(o0.5 μm in length) and mushroom (0.5–1.25 μm in length)
subclasses of spines, at the expense of thin spines (1.25–3.0 μm in
length) and immature ﬁlopodia (length exceeded 3 μm;
Figure 4g). This was signiﬁcant when either analyzed as odds
ratio for being in a shorter-length category or if protrusion length
was log transformed and estimates back transformed. There was
no signiﬁcance difference in the proportion of spine subclass in
the IQSEC2E849K mutant treatment group compared with either
GFP alone or wild-type IQSEC2 overexpression (Figure 4g).
Neurons from Iqsec2 knockout mice exhibit gross morphological
disturbances during early growth and development
Aspects of the disturbances to gross morphology of hippocampal
neurons due to knockdown of Iqsec2 in vitro were recapitulated in
cortical neurons harvested from Iqsec2 knockout mice (Figure 5).
Knockout of Iqsec2 expression was achieved by targeting CRISPR/
Cas9 removal of exon 3 in a C57Bl/6 background (Figure 5a).
Although the behavioral and phenotypic characterization of this
knockout mouse is ongoing (MRJ, personal communication) and
outside the scope of the current report, we have conﬁrmed
transmission of the exon 3 removal and subsequent loss of Iqsec2
mRNA expression and Iqsec2 protein in hemizygous male
knockout offspring (Figure 5a). Heterozygous Iqsec2 knockout
females were time-mated with wild-type males and cortical
neurons extracted from individual embryos at E17.5 days post
coitum (d.p.c.). Concomitant genotyping from tail material of each
embryo allowed us to pool genotypically relevant neurons before
culturing cells as outlined for shRNA cultures.
At 7DIV, the cells were transfected with a 0.5 μg spike of
pmaxGFP to visualize individual neurons and cells collected and
ﬁxed 24 h later (8DIV). Iqsec2 knockout neurons were more
disorganized in their arrangement when compared with neurons
from wild-type littermates (Figure 5b). Unlike the knockdown or
overexpression neurons, there were no signiﬁcant disturbances to
the number of projections from the cell body or branching of the
neurites (number of termini) in the knockout neurons compared
with neurons from wild-type littermates (data not shown). We
cannot rule out that use of cortical cultures in the case of KO
neurons as opposed to hippocampal neurons in culture for the
shRNA knockdown experiments may contribute to this discre-
pancy. In keeping with the data from the shRNA knockdown, we
did note a trend towards longer dendritic processes from the cell
body in Iqsec2 knockout neurons (56%) when compared with
neurons extracted from their wild-type littermates (47%). How-
ever, this did not reach signiﬁcance (Figure 5e). Similar to previous
manipulation of Iqsec2/IQSEC2, the primary axon was sensitive to
complete loss of Iqsec2. Although the majority of primary axons in
wild-type neurons (59%) followed a deﬁned course, or displayed a
limited change in direction (under 45 degrees = 1 quadrant), 72%
of primary axons in Iqsec2 knockout neurons altered their course
on average by more than 90 degrees (two quadrants; Figures 5c
and d; Chi-squared test P= 0.0082 and P= 0074, respectively).
DISCUSSION
We provide experimental support for a role of Iqsec2 in
modulating the morphology of developing neurons, including
the development of dendritic spines. We show increased
complexity and spread of neurite processes in neurons with
knockdown of Iqsec2, whereas by contrast, increased expression of
IQSEC2 leads to neurons with shorter axons that are more compact
and display simpler dendritic branching. Observations in neurons
obtained from hemizygous Iqsec2 knockout mice support the
impact of Iqsec2 on neuronal morphology and, in particular,
highlight that disturbances in the expression levels of Iqsec2
disrupt normal axonal development. Taken together, the data
from our investigations provide evidence of dosage sensitivity for
this X-chromosome gene that normally escapes X-inactivation in
humans (but not in mice) and links for, to the best of our
knowledge, the ﬁrst time these disturbances in expression with
alterations in the morphology of developing neurons.
IQSEC2 catalyzes exchange of GDP for GTP in some members of
the ARF protein superfamily. The identiﬁcation of variants in
families with X-linked intellectual disability that clustered around
the Sec7 and IQ-like domains and resulted in reduced enzymatic
activity, provided strong evidence that missense mutations in
IQSEC2 cause a neurocognitive disability.18 Affected male patients
with these variants displayed non-syndromic ID, with variable
penetrance of other comorbidities such as autistic spectrum
disorders and seizures. The females in these families were
generally well and did not display a consistent phenotype, but
there was variable penetrance of carrier females being less
academically able compared with non-carrier siblings.18 Initially, it
was unclear whether loss-of-function variants in IQSEC2 in males
would be compatible with life.
What was known about IQSEC2, also referred to as BRAG1, was
that levels of expression increased with postnatal development
with the strongest expression in the brain, particularly in the
cerebellum, cortex and hippocampus, including the dentate
gyrus.7,8 Moreover, Iqsec2 is localized to excitatory synapses as
part of the NMDA receptor complex, via interactions with
postsynaptic density proteins DLG1, DLG2, DLG3 and DLG4.8
Iqsec2 mRNA and protein have been identiﬁed at dendrites
suggesting that Iqsec2 mRNA might be locally translated in an
activity-dependent manner thereby contributing to synaptic
plasticity. This body of evidence underscores the role for IQSEC2
in the fundamental process of dendritic development. Our study
aimed to examine the impact of Iqsec2 on this process, and using
a knockdown approach we have demonstrated for the ﬁrst time
that reduced expression of Iqsec2 resulted in increased neurite
processes in hippocampal neurons at early time points in culture,
with a transient increase in the density of protrusions at 15 days
in vitro and a propensity for shorter more mature dendritic spines
after 21 days. The utility of these types of investigations is
highlighted by the elegant original study by Govek et al.9 in which
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RNA interference was used to model naturally occurring OPHN1
mutations in CA1 neurons, with downregulation of this gene
resulting in signiﬁcantly shortened dendritic spines, shown to be
related to RhoA/Rho-kinase signaling pathway. More broadly,
patients and animal models of neurodevelopmental disorders
with early childhood onset show hallmarks of immature synaptic
networks, in the form of an increased ﬁlopodia-to-spine ratio or
abnormal density of protrusions.16,17
In contrast to the deﬁcits to IQSEC2 function, we have recently
reported four male patients with ID with early speech disturbances
with submicroscopic duplications at Xp11.22 containing the
known ID genes IQSEC2, KDM5C and TSPYL2.30 These data
indicated that IQSEC2 may be a dosage-sensitive gene. Hence,
we wanted to investigate the impact of dosage of IQSEC2 in our
neuronal culture model. Overexpression of wild-type IQSEC2
resulted in a signiﬁcant decrease in the number of neurite
processes at the early stages of neuron culture, the opposite trend
to that observed in our knockdown studies. We also observed a
signiﬁcant shift toward shorter, more mature dendritic spines with
overexpression of wild-type IQSEC2 for 3 weeks in culture. These
observations provide additional support for dosage sensitivity of
IQSEC2. In support, a recent study demonstrated that IQSEC2
modulates AMPA receptor-mediated synaptic transmission in a
bidirectional manner: with IQSEC2 knockdown reducing synaptic
transmission, but overexpression enhancing transmission.36 Taken
together, these observations provide additional support for
dosage sensitivity of IQSEC2.
As the ﬁrst variants reported for IQSEC2, high-throughput
sequencing in ID and epilepsy cohorts has increasingly identiﬁed
de novo loss-of-function IQSEC2 mutations in males and increas-
ingly in females.19–29 Complete abolition of enzymatic activity
does not lead to lethality, but instead leads to a severe phenotype
including epileptic encephalopathy in both males and females.
The novel Iqsec2 knockout mouse we have generated is viable
during postnatal life (both hemizygous males and herterozygous
females) and provides a valuable resource to better interrogate
the impact of Iqsec2 dysfunction. Harnessing neurons from this
knockout mouse in culture, we were able to re-capitulate some of
the ﬁndings from our shRNA knockdown studies, in particular of
the gross morphological studies seen at early stages of neuronal
development. Interestingly, we noted discrepancies in several
morphological measures in the KO neurons when compared with
the shRNA knockdown studies. We cannot exclude at least some
contribution due to the technical nature of the different
experiments (that is, neurons cultured from different mouse
strains and hippocampal vs cortical neuronal cultures). However, a
less pedestrian consideration may be that the differences we see
between the two approaches represent contributors to the
spectrum of phenotypic outcomes that we see in patients with
various mutation types in IQSEC2. This perhaps reﬂects that a
partial loss of function of a particular gene may have a very
different impact compared with a complete loss of function in the
same setting. Indeed, this has been noted for many non-
syndromic ID genes. In contrast, one of the most interesting
ﬁndings evident across each of the manipulations we undertook
in this study, was the negative impact on axon length,
morphology and directionality when expression of Iqsec2/IQSEC2
was disturbed. When another ARFGEF (EFA6A) is ablated, a
decrease in spine formation in noted.37 Investigating the role of
ARF6 in conjunction with EFA6A indicates that ARF6 knockdown
decreases the conversion of ﬁlopodia to spines and stability of
early spines.37 The IQSEC family display a unique domain structure
compared with all other ArfGEFs, each containing a coiled-coiled
domain (CC), an IQ-like domain (IQ), the catalytic SEC7 domain
(Sec7) and a Pleckstrin Homology domain. We speculate that
compromise of functions other than just the Sec7 catalytic activity
of IQSEC2 might be contributing to the disturbed morphology of
the neurons following altered levels of Iqsec2/IQSEC2. The
preferential accumulation of IQSEC2 in the tips of dendritic spines
has been shown to be altered with the removal of last 74 amino
acids, implicating the C terminus of IQSEC2,38 which contains a
PDZ domain binding motif. A recent study strengthens this
ﬁnding, with IQSEC2 expression enhancing synaptic transmission
independently of Arf-GEF or neuronal activity, but dependent on
IQSEC2 C-terminal interactions.36 In regard to the other IQSEC
family members, there is no known disease-causing mutations in
either IQSEC1 or IQSEC3 currently described. The role of these
proteins on synaptic function, particularly for the other predomi-
nately brain expressed member, IQSEC3, is growing and has
recently been reviewed.39
The Iqsec2 knockout mouse reported here has the potential to
provide a platform to address broader questions relating to
functional aspects of this interesting gene. For example, these
neurons will provide a potential means to establish the role that
Iqsec2 has speciﬁcally in modulating activity-dependent processes
downstream of signaling via the NMDA receptor. In addition, the
deﬁcits due to speciﬁc patient mutations in IQSEC2 may be
modeled using rescue experiments, to assist in determining the
pathogenicity of variants of unknown signiﬁcance. Moreover,
treatments to improve aspects of the development of neurons
when IQSEC2 function is deﬁcient may be modeled. In conclusion,
our study has utilized a range of approaches to knockdown,
overexpress or completely knockout Iqsec2/IQSEC2 expression in
primary hippocampal neurons. We have demonstrated a role for
this known ID and seizure gene on the morphology of the neuron
and development of dendritic spines, including a negative impact
on the growth of neuronal axons. These observations provide
support for dosage sensitivity for IQSEC2, which normally escapes
X-inactivation in humans and for the ﬁrst time links these
disturbances in expression with speciﬁc alterations to the
morphology of developing neurons.
CONFLICT OF INTEREST
The authors declare no conﬂict of interest.
ACKNOWLEDGMENTS
The full-length IQSEC2 cDNA in pCAGGS were a kind gift from Dr Randall Walikonis
(University of Connecticut, USA). The Intellectual Disability research program in the
Department of Paediatrics, University of Adelaide, Australia was funded by the
Australian National Health and Medical Research Council (NHMRC) (Grant No.
1006586), and the Channel 7 Children’s Research Foundation (Grant No. 161263). CS
is supported by the Australian Research Council (Future Fellowship FT120100086).
REFERENCES
1 Sekino Y, Kojima N, Shirao T. Role of actin cytoskeleton in dendritic spine mor-
phogenesis. Neurochem Int 2007; 51: 92–104.
2 Ethell IM, Pasquale EB. Molecular mechanisms of dendritic spine development
and remodeling. Prog Neurobiol 2005; 75: 161–205.
3 West AE, Greenberg ME. Neuronal activity-regulated gene transcription in
synapse development and cognitive function. Cold Spring Harb Perspect Biol 2011;
3: a005744.
4 Grillo FW, Song S, Teles-Grilo Ruivo LM, Huang L, Gao G, Knott GW et al. Increased
axonal bouton dynamics in the aging mouse cortex. Proc Natl Acad Sci USA 2013;
110: E1514–E1523.
5 Shirao T, Sekino Y. Clustering and anchoring mechanisms of molecular con-
stituents of postsynaptic scaffolds in dendritic spines. Neurosci Res 2001; 40: 1–7.
6 Casanova JE. Regulation of Arf activation: the Sec7 family of guanine nucleotide
exchange factors. Trafﬁc 2007; 8: 1476–1485.
7 Murphy JA, Jensen ON, Walikonis RS. BRAG1, a Sec7 domain-containing protein, is
a component of the postsynaptic density of excitatory synapses. Brain Res 2006;
1120: 35–45.
8 Sakagami H, Sanda M, Fukaya M, Miyazaki T, Sukegawa J, Yanagisawa T et al. IQ-
ArfGEF/BRAG1 is a guanine nucleotide exchange factor for Arf6 that interacts with
PSD-95 at postsynaptic density of excitatory synapses. Neurosci Res 2008; 60:
199–212.
IQSEC2 has a key role in dendritic spine morphology
SJ Hinze et al
10
Translational Psychiatry (2017), 1 – 11
9 Govek EE, Newey SE, Akerman CJ, Cross JR, Van der Veken L, Van Aelst L. The
X-linked mental retardation protein oligophrenin-1 is required for dendritic spine
morphogenesis. Nat Neurosci 2004; 7: 364–372.
10 Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP et al.
Abnormal dendritic spine characteristics in the temporal and visual cortices of
patients with fragile-X syndrome: a quantitative examination. Am J Med Genet
2001; 98: 161–167.
11 Pfeiffer BE, Huber KM. Fragile X mental retardation protein induces synapse loss
through acute postsynaptic translational regulation. J Neurosci 2007; 27:
3120–3130.
12 Laumonnier F, Cuthbert PC, Grant SG. The role of neuronal complexes in human
X-linked brain diseases. Am J Hum Genet 2007; 80: 205–220.
13 Kutsche K, Yntema H, Brandt A, Jantke I, Nothwang HG, Orth U et al. Mutations in
ARHGEF6, encoding a guanine nucleotide exchange factor for Rho GTPases, in
patients with X-linked mental retardation. Nat Genet 2000; 26: 247–250.
14 Lebel RR, May M, Pouls S, Lubs HA, Stevenson RE, Schwartz CE. Non-syndromic
X-linked mental retardation associated with a missense mutation (P312L) in the
FGD1 gene. Clin Genet 2002; 61: 139–145.
15 Gecz J, Shoubridge C, Corbett M. The genetic landscape of intellectual disability
arising from chromosome X. Trends Genet 2009; 25: 308–316.
16 Ramakers GJ, Wolfer D, Rosenberger G, Kuchenbecker K, Kreienkamp HJ, Prange-
Kiel J et al. Dysregulation of Rho GTPases in the alphaPix/Arhgef6 mouse model of
X-linked intellectual disability is paralleled by impaired structural and synaptic
plasticity and cognitive deﬁcits. Hum Mol Genet 2012; 21: 268–286.
17 Meredith RM, Dawitz J, Kramvis I. Sensitive time-windows for susceptibility in
neurodevelopmental disorders. Trends Neurosci 2012; 35: 335–344.
18 Shoubridge C, Tarpey PS, Abidi F, Ramsden SL, Rujirabanjerd S, Murphy JA et al.
Mutations in the guanine nucleotide exchange factor gene IQSEC2 cause
nonsyndromic intellectual disability. Nat Genet 2010; 42: 486–488.
19 Rauch A, Wieczorek D, Graf E, Wieland T, Endele S, Schwarzmayr T et al. Range of
genetic mutations associated with severe non-syndromic sporadic intellectual
disability: an exome sequencing study. Lancet 2012; 380: 1674–1682.
20 Epi4K Consortium, Epilepsy Phenome/Genome Project, Allen AS, Berkovic SF,
Cossette P, Delanty N et al. De novo mutations in epileptic encephalopathies.
Nature 2013; 501: 217–221.
21 Gandomi SK, Farwell Gonzalez KD, Parra M, Shahmirzadi L, Mancuso J,
Pichurin P et al. Diagnostic exome sequencing identiﬁes two novel IQSEC2
mutations associated with X-linked intellectual disability with seizures: implica-
tions for genetic counseling and clinical diagnosis. J Genet Couns 2014; 23:
289–298.
22 Redin C, Gerard B, Lauer J, Herenger Y, Muller J, Quartier A et al. Efﬁcient strategy
for the molecular diagnosis of intellectual disability using targeted high-
throughput sequencing. J Med Genet 2014; 51: 724–736.
23 Olson HE, Tambunan D, LaCoursiere C, Goldenberg M, Pinsky R, Martin E et al.
Mutations in epilepsy and intellectual disability genes in patients with features of
Rett syndrome. Am J Med Genet A 2015; 167A: 2017–2025.
24 Tzschach A, Grasshoff U, Beck-Woedl S, Dufke C, Bauer C, Kehrer M et al.
Next-generation sequencing in X-linked intellectual disability. Eur J Hum Genet
2015; 23: 1513–1518.
25 Kalscheuer VM, James VM, Himelright ML, Long P, Oegema R, Jensen C et al.
Novel missense mutation A789V in IQSEC2 underlies X-Linked intellectual dis-
ability in the MRX78 family. Front Mol Neurosci 2015; 8: 85.
26 Helbig KL, Farwell Hagman KD, Shinde DN, Mroske C, Powis Z, Li S et al. Diag-
nostic exome sequencing provides a molecular diagnosis for a signiﬁcant pro-
portion of patients with epilepsy. Genet Med 2016; 18: 898–905.
27 Allou L, Julia S, Amsallem D, El Chehadeh S, Lambert L, Thevenon J et al. Rett-like
phenotypes: expanding the genetic heterogeneity to the KCNA2 gene and ﬁrst
familial case of CDKL5-related disease. Clin Genet 2017; 91: 431–440.
28 KCEaekce Epi, Epi KC. De novo mutations in SLC1A2 and CACNA1A are important
causes of epileptic encephalopathies. Am J Hum Genet 2016; 99: 287–298.
29 Zerem A, Haginoya K, Lev D, Blumkin L, Kivity S, Linder I et al. The molecular and
phenotypic spectrum of IQSEC2 related epilepsy. Epilepsia 2016; 57: 1858–1869.
30 Moey C, Hinze SJ, Brueton L, Morton J, McMullan DJ, Kamien B et al. Xp11.2
microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with
neurodevelopmental disorders. Eur J Hum Genet 2016; 24: 373–380.
31 Brown CY, Sadlon T, Gargett T, Melville E, Zhang R, Drabsch Y et al. Robust,
reversible gene knockdown using a single lentiviral short hairpin RNA vector. Hum
Gene Ther 2010; 21: 1005–1017.
32 Shoubridge C, Cloosterman D, Parkinson-Lawerence E, Brooks D, Gecz J. Mole-
cular pathology of expanded polyalanine tract mutations in the Aristaless-related
homeobox gene. Genomics 2007; 90: 59–71.
33 Vanderklish PW, Edelman GM. Dendritic spines elongate after stimulation of
group 1 metabotropic glutamate receptors in cultured hippocampal neurons.
Proc Natl Acad Sci USA 2002; 99: 1639–1644.
34 Papa M, Bundman MC, Greenberger V, Segal M. Morphological analysis of den-
dritic spine development in primary cultures of hippocampal neurons. J Neurosci
1995; 15(1 Pt 1): 1–11.
35 Beraud-Dufour S, Robineau S, Chardin P, Paris S, Chabre M, Cherﬁls J et al. A
glutamic ﬁnger in the guanine nucleotide exchange factor ARNO displaces Mg2+
and the beta-phosphate to destabilize GDP on ARF1. EMBO J 1998; 17:
3651–3659.
36 Brown JC, Petersen A, Zhong L, Himelright ML, Murphy JA, Walikonis RS et al.
Bidirectional regulation of synaptic transmission by BRAG1/IQSEC2 and its
requirement in long-term depression. Nat Commun 2016; 7: 11080.
37 Choi S, Ko J, Lee JR, Lee HW, Kim K, Chung HS et al. ARF6 and EFA6A regulate the
development and maintenance of dendritic spines. J Neurosci 2006; 26:
4811–4819.
38 Sanda M, Kamata A, Katsumata O, Fukunaga K, Watanabe M, Kondo H et al. The
postsynaptic density protein, IQ-ArfGEF/BRAG1, can interact with IRSp53 through
its proline-rich sequence. Brain Res 2009; 1251: 7–15.
39 Um JW. Synaptic functions of the IQSEC family of ADP-ribosylation factor guanine
nucleotide exchange factors. Neurosci Res 2017; 116: 54–59.
This work is licensed under a Creative Commons Attribution 4.0
International License. The images or other third party material in this
article are included in the article’s Creative Commons license, unless indicated
otherwise in the credit line; if the material is not included under the Creative Commons
license, users will need to obtain permission from the license holder to reproduce the
material. To view a copy of this license, visit http://creativecommons.org/licenses/
by/4.0/
© The Author(s) 2017
Supplementary Information accompanies the paper on the Translational Psychiatry website (http://www.nature.com/tp)
IQSEC2 has a key role in dendritic spine morphology
SJ Hinze et al
11
Translational Psychiatry (2017), 1 – 11
